| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Aselage Steve is a Director at TVTX, with reported holdings spanning 2 companies. Recent filings cover 5 purchases and 42 sales. Those positions are worth an estimated $3.2M at current prices.
Our model assigns Aselage Steve a strong insider score of 80/100, based on 10 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +20.1%.
Aselage Steve's largest disclosed position is in TVTX as Director, worth about $3.2M. The recent filings there lean toward selling, a net 343,789 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2016 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 8,200 | $21.12 | $173,160.00 | -3.3% | |
| Nov 10, 2015 | TVTX Travere Therapeutics, Inc. | Chief Executive Officer | Sell | 60,000 | $18.75 | $1,124,700.00 | -16.3% |